Calls for papers
-
US biotech company Generex has announced that the Canadian Intellectual Property Office has granted its patent titled "Pharmaceutical Compositions for Buccal and Pulmonary Application." Generex develops formulations for buccal delivery using its RapidMist metered dose… Read more . . .
-
Shareholders of pharma companies Biovail and Valeant voted to approve their merger, and the new company is now called Valeant Pharmaceuticals International. Valeant markets Migranal dihydroergotamine nasal spray in the US, and Biovail had been… Read more . . .
-
According to Stirling Products, the company is in discussions with several major pharmaceutical companies about partnerships on products using its patented high density aerosol (HDA) device. The company says that its ultrasound-based HDA technology produces… Read more . . .
-
The European Commission’s Committee for Medicinal Products for Human Use (CHMP) has recommended approval of Novartis’s TOBI Podhaler tobramycin inhalation powder for the treatment of P. aeruginosa infections in cystic fibrosis patients. Novartis submitted the… Read more . . .
-
Dutch vaccine developer Mucosis has announced that John Lambert has been elected as the new chairman of its supervisory board. Mucosis is developing vaccines based on particles created from inactivated Lactococcus lactis bacteria, including its… Read more . . .
-
GlaxoSmithKline has announced that the Relovair fluticasone furoate/vilanterol trifenatate DPI it is developing with Theravance showed good results in a Phase II study involving 60 COPD patients. Studies of the component drugs for asthma also… Read more . . .
-
Automation company RTS Life Science has formed a new team comprised of US and UK engineering and sales personnel. The move comes after the recent acquisition of a Massacheusetts company and the opening of a… Read more . . .
-
Jamie Clayton has been appointed Operations Manager for Freeman Technology, responsible for all day-to-day operations, including R&D, production, and sales. According to Freeman, it added the position in anticipation of further growth for the company,… Read more . . .
-
A study by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) shows that a combination of tiotropium bromide with a low dose of inhaled corticosteroid (ICS) provides better… Read more . . .
-
Novartis has announced that its Phase III INSIST study shows that its once-daily Onbrez Breezhaler indacaterol DPI produces better bronchodilation in COPD patients than does twice-daily salmeterol. Onbrez also reduced the need for rescue medication,… Read more . . .
Upcoming Events
Sponsored by Intertek
Want information about upcoming OINDP-related events delivered directly to your inbox? click here
September 15-September 18: DDL New Researcher Network Summer Event, London, UK
September 16-September 17: IPAC-RS 2026 Nasal Innovation Forum, Jersey City, NJ, USA
September 24-September 25: Inhaled & Nasal Biologics | DNA Forum, Cambridge, UK
October 14-October 15: Advancing Bioequivalence Frameworks for Inhalation and Nasal Drug Products: Optimizing In Vitro, In Vivo, and In Silico Methods, Rockville, MD, USA
October 19-October 20: MVIC Autumn Training 2026, Lund, Sweden